NJ State Employees Deferred Compensation Plan - ARATANA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$568,000
+125.4%
110,000
+57.1%
0.10%
+121.7%
Q1 2019$252,000
+37.0%
70,000
+133.3%
0.05%
+21.1%
Q4 2018$184,000
-82.0%
30,000
-82.9%
0.04%
-78.2%
Q3 2018$1,022,000
+33.6%
175,000
-2.8%
0.17%
+27.0%
Q2 2018$765,000
+2.0%
180,000
+5.9%
0.14%
+2.2%
Q1 2018$750,000
+1.9%
170,000
+21.4%
0.13%
+5.5%
Q4 2017$736,000140,0000.13%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,184,942$31,784,0004.70%
AWM Investment Company, Inc. 1,562,517$9,578,0001.67%
Opaleye Management Inc. 420,000$2,574,0000.91%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0000.75%
GENERAL AMERICAN INVESTORS CO INC 867,600$5,318,0000.50%
Grandeur Peak Global Advisors, LLC 538,363$3,300,0000.50%
Redmond Asset Management, LLC 55,941$343,0000.16%
WOODSTOCK CORP 88,303$541,0000.10%
CADENCE CAPITAL MANAGEMENT LLC 173,808$1,065,0000.07%
Sheaff Brock Investment Advisors, LLC 71,000$435,0000.06%
View complete list of ARATANA THERAPEUTICS INC shareholders